Introduction
Shanxi Hanjiang Pharmaceutical Group Co., Ltd was founded as Shaanxi Hanjiang Pharmacy Factory in 1970. By 30 years’development, Shaanxi Hanjiang Pharmaceutical Group Co.,Ltd has become a large-scale pharmaceutical group company specializing in the production and trade of APIs, intermediates, preparation and the planting of GAP standardized Chinese traditional medicines, with12 share and holding companies in total, 4 are Sino-foreign joint venture companies and 5 are holding companies.
At present, the company covers an area of 180,000m2 and has 1,100 employees, 328 of them are technicians. Up to now, Hanjiang has been a pharmaceutical researcher, developer, manufacturer and trader for 30 years. Taking such spirit of "The newer, the faster, the better and stronger" and tenet of "Standing in domestic and facing the world market, providing high-quality product and bringing benefit to mankind”, we are seeking for the latest management idea, faster developing speed, better quality continuously to form stronger strength in competition. With advanced equipments, topping QC methods and strict manufacture control based on GMP, Hanjiang now can produce multi- products at the same time; Moreover, 4 main production lines in the company have passed GMP and it is one of the enterprises to take the lead in passing GMP for API in China, and it was ISO14001 certified by State Environmental Administration System in 2002. Besides, Hanjiang is one of the model enterprises for environment protection in China. Up to now, we have had 4 FDA approved products and 8 COS approved products in Europe.
The products have already been sold in markets of 29 provinces and cities in China and over 40 countries and areas such as Europe, America, Asian and Pacific area and Hong Kong. It has the experiences of 20 years or more in cooperation with several famous international pharmaceutical companies on the field of technology and trade. The comprehensive capability of the company ranked among the best of the successful enterprises in China.